InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by LaChapelle Robin. Officer active across 1 company, notably ArriVent Biopharma, Inc.. Aggregated, 4 reports have been recorded. Activity tracked since 19 September 2024. The latest transaction was filed on 11 July 2025 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
LaChapelle Robin is linked to ArriVent Biopharma, Inc. as Chief Operating Officer. The declarant has 4 filings in total, and in the sampled recent filings from 2024-09-23 to 2025-07-15, the modal transaction nature is option exercise, with sum_buy_eur at 0 and sum_sell_eur at 0.